Oxidases and reactive oxygen species during hematopoiesis: A focus on megakaryocytes

Journal of Cellular Physiology

Volumn 227, Issue 10, 2012, Pages 3355-3362

  Eliades, Alexia ^a   Matsuura, Shinobu ^a   Ravid, Katya ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CATALASE; ERYTHROPOIETIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; JANUS KINASE 2 INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; OXIDOREDUCTASE; PEROXIREDOXIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN C FOS; PROTEIN KINASE C; PROTEIN LYSINE 6 OXIDASE; RAF PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; STAT3 PROTEIN; STAT5 PROTEIN; STEM CELL FACTOR; SYNAPTOPHYSIN; THROMBOPOIETIN; TOLL LIKE RECEPTOR 2;

AUTOPHAGY; CATALYSIS; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CYTOLOGY; ENERGY YIELD; ERYTHROBLASTOSIS; GENE MUTATION; HUMAN; MACROCYTIC ANEMIA; MEGAKARYOPOIESIS; MITOCHONDRION; MITOSIS; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NONHUMAN; PATHOGENESIS; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ANIMALS; HEMATOPOIESIS; HUMANS; MEGAKARYOCYTES; OXIDOREDUCTASES; REACTIVE OXYGEN SPECIES;

EID: 84862649105     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24071     Document Type: Review

References (132)

1. Abe MK, Kartha S, Karpova AY, Li J, Liu PT, Kuo WL, Hershenson MB. 1998. Hydrogen peroxide activates extracellular signal-regulated kinase via protein kinase C, Raf-1, and MEK1. Am J Respir Cell Mol Biol 18: 562- 569.
2. Adams GB, Scadden DT. 2006. The hematopoietic stem cell in its place. Nat Immunol 7: 333- 337.
3. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193- 197.
4. Battinelli E, Loscalzo J. 2000. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood 95: 3451- 3459.
5. Beaulieu LM, Lin E, Morin KM, Tanriverdi K, Freedman JE. 2011. Regulatory effects of TLR2 on megakaryocytic cell function. Blood 117: 5963- 5974.
6. Bedard K, Krause KH. 2007. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245- 313.
7. Besancenot R, Chaligne R, Tonetti C, Pasquier F, Marty C, Lecluse Y, Vainchenker W, Constantinescu SN, Giraudier S. 2010. A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: Implications for physiological and pathological megakaryocytic proliferation. PLoS Biol 8: 1- 11.
8. Boonstra J, Post JA. 2004. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337: 1- 13.
9. Buscher M, Rahmsdorf HJ, Litfin M, Karin M, Herrlich P. 1988. Activation of the c-fos gene by UV and phorbol ester: Different signal transduction pathways converge to the same enhancer element. Oncogene 3: 301- 311.
10. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. 2010. Multiple roles of the cell cycle inhibitor p21 (CDKN1A) in the DNA damage response. Mutat Res 704: 12- 20.
11. Centurione L, Di Baldassarre A, Zingariello M, Bosco D, Gatta V, Rana RA, Langella V, Di Virgilio A, Vannucchi AM, Migliaccio AR. 2004. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 104: 3573- 3580.
12. Chiarugi P. 2001. The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life 52: 55- 59.
13. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. 2005. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435: 347- 353.
14. Chui CM, Li K, Yang M, Chuen CK, Fok TF, Li CK, Yuen PM. 2003. Platelet-derived growth factor up-regulates the expression of transcription factors NF-E2, GATA-1 and c-Fos in megakaryocytic cell lines. Cytokine 21: 51- 64.
15. Colosetti P, Puissant A, Robert G, Luciano F, Jacquel A, Gounon P, Cassuto JP, Auberger P. 2009. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line. Autophagy 5: 1092- 1098.
16. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. 2007. Myelodysplastic syndromes: The complexity of stem-cell diseases. Nat Rev Cancer 7: 118- 129.
17. Das A, Dey N, Ghosh A, Das T, Chatterjee IB. 2011. NAD(P)H:quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes. PLoS ONE 6: e20590.
18. D'Autreaux B, Toledano MB. 2007. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813- 824.
19. Deutsch VR, Tomer A. 2006. Megakaryocyte development and platelet production. Br J Haematol 134: 453- 466.
20. Drayer AL, Olthof SG, Vellenga E. 2006. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors. Stem Cells 24: 105- 114.
21. Eliades A, Papadantonakis N, Ravid K. 2010. New roles for cyclin E in megakaryocytic polyploidization. J Biol Chem 285: 18909- 18917.
22. Eliades A, Papadantonakis N, Bhupatiraju A, Burridge KA, Johnston-Cox HA, Migliaccio AR, Crispino JD, Lucero HA, Trackman PC, Ravid K. 2011. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem 286: 27630- 27638.
23. Eliasson P, Jonsson JI. 2010. The hematopoietic stem cell niche: Low in oxygen but a nice place to be. J Cell Physiol 222: 17- 22.
24. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222- 1226.
25. Farquhar MJ, Bowen DT. 2003. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 77: 342- 350.
26. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239- 247.
27. Gattermann N. 2004. Mitochondrial DNA mutations in the hematopoietic system. Leukemia 18: 18- 22.
28. Geiszt M. 2006. NADPH oxidases: New kids on the block. Cardiovasc Res 71: 289- 299.
29. Ghaffari S. 2008. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 10: 1923- 1940.
30. Gilad GM, Kagan HM, Gilad VH. 2001. Lysyl oxidase, the extracellular matrix-forming enzyme, in rat brain injury sites. Neurosci Lett 310: 45- 48.
31. Gilad GM, Kagan HM, Gilad VH. 2005. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci Lett 376: 210- 214.
32. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M, Marx M. 1996. Oxidative stress induces tyrosine phosphorylation of PDGF alpha-and beta-receptors and pp60c-src in mesangial cells. Kidney Int 50: 164- 173.
33. Grek CL, Townsend DM, Tew KD. 2011. The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies. Pharmacol Ther 129: 172- 184.
34. Guadall A, Orriols M, Alcudia JF, Cachofeiro V, Martinez-Gonzalez J, Rodriguez C. 2011. Hypoxia-induced ROS signaling is required for LOX up-regulation in endothelial cells. Front Biosci (Elite Ed) 3: 955- 967.
35. Halliwell B. 1999. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Radic Res 31: 261- 272.
36. Havens CG, Ho A, Yoshioka N, Dowdy SF. 2006. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol 26: 4701- 4711.
37. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265: 2896- 2902.
38. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA. 2001. p53-Dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci 63: 214- 222.
39. Hole PS, Darley RL, Tonks A. 2011. Do reactive oxygen species play a role in myeloid leukemias? Blood 117: 5816- 5826.
40. Houwerzijl EJ, Pol HW, Blom NR, van der Want JJ, de Wolf JT, Vellenga E. 2009. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria. Leukemia 23: 886- 891.
41. Iiyama M, Kakihana K, Kurosu T, Miura O. 2006. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 18: 174- 182.
42. Italiano JE, Jr., Patel-Hett S, Hartwig JH. 2007. Mechanics of proplatelet elaboration. J Thromb Haemost 5: 18- 23.
43. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, Suda T. 2006. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446- 451.
44. Jang YY, Sharkis SJ. 2007. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110: 3056- 3063.
45. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, Wagner DD, Graf T, Italiano JE, Jr., Shivdasani RA, von Andrian UH. 2007. Dynamic visualization of thrombopoiesis within bone marrow. Science 317: 1767- 1770.
46. Kagan HM, Li W. 2003. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88: 660- 672.
47. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649- 661.
48. Kaminski WE, Lindahl P, Lin NL, Broudy VC, Crosby JR, Hellstrom M, Swolin B, Bowen-Pope DF, Martin PJ, Ross R, Betsholtz C, Raines EW. 2001. Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 97: 1990- 1998.
49. Kaushansky K. 1999. The enigmatic megakaryocyte gradually reveals its secrets. Bioessays 21: 353- 360.
50. Kaushansky K. 2008. Historical review: Megakaryopoiesis and thrombopoiesis. Blood 111: 981- 986.
51. Kaushansky K, Drachman JG. 2002. The molecular and cellular biology of thrombopoietin: The primary regulator of platelet production. Oncogene 21: 3359- 3367.
52. Kietzmann T, Hirsch-Ernst KI, Kahl GF, Jungermann K. 1999. Mimicry in primary rat hepatocyte cultures of the in vivo perivenous induction by phenobarbital of cytochrome P-450 2B1 mRNA: Role of epidermal growth factor and perivenous oxygen tension. Mol Pharmacol 56: 46- 53.
53. Kim I, Han SJ, Kim Y, Ahn Y, Chay KO, Lee SR. 2011. Tyr740 and Tyr751 residues of platelet-derived growth factor beta receptor are responsible for the redox regulation of phosphatase and tensin homolog in the cells stimulated with platelet-derived growth factor. Redox Rep 16: 181- 186.
54. Klebanoff SJ. 2005. Myeloperoxidase: Friend and foe. J Leukoc Biol 77: 598- 625.
55. Klotz LO, Schieke SM, Sies H, Holbrook NJ. 2000. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352: 219- 225.
56. Knowles RG, Moncada S. 1994. Nitric oxide synthases in mammals. Biochem J 298: 249- 258.
57. Kopp HG, Avecilla ST, Hooper AT, Rafii S. 2005. The bone marrow vascular niche: Home of HSC differentiation and mobilization. Physiology (Bethesda) 20: 349- 356.
58. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. 2009. Mitochondria and reactive oxygen species. Free Radic Biol Med 47: 333- 343.
59. Kuehl FA, Jr., Egan RW. 1980. Prostaglandins, arachidonic acid, and inflammation. Science 210: 978- 984.
60. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. 2007. Bone marrow fibrosis: Pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 139: 351- 362.
61. LaIuppa JA, Papoutsakis ET, Miller WM. 1998. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol 26: 835- 843.
62. Lazarus HM, Cruikshank WW, Narasimhan N, Kagan HM, Center DM. 1995. Induction of human monocyte motility by lysyl oxidase. Matrix Biol 14: 727- 731.
63. Le Bousse-Kerdiles MC, Martyre MC. 1999. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol 78: 437- 444.
64. Le Bousse-Kerdiles MC, Martyre MC, Samson M. 2008. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: A review. Eur Cytokine Netw 19: 69- 80.
65. Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875- 1887.
66. Li Z, Li L. 2006. Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 31: 589- 595.
67. Li W, Liu G, Chou IN, Kagan HM. 2000. Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J Cell Biochem 78: 550- 557.
68. Lucero HA, Kagan HM. 2006. Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell Mol Life Sci 63: 2304- 2316.
69. Lucero HA, Ravid K, Grimsby JL, Rich CB, DiCamillo SJ, Maki JM, Myllyharju J, Kagan HM. 2008. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J Biol Chem 283: 24103- 24117.
70. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, Soininen R. 2002. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106: 2503- 2509.
71. Martindale JL, Holbrook NJ. 2002. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192: 1- 15.
72. McCarthy DM. 1985. Annotation. Fibrosis of the bone marrow: Content and causes. Br J Haematol 59: 1- 7.
73. McCrann DJ, Eliades A, Makitalo M, Matsuno K, Ravid K. 2009a. Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy. Blood 114: 1243- 1249.
74. McCrann DJ, Yang D, Chen H, Carroll S, Ravid K. 2009b. Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy. Cell Cycle 8: 902- 908.
75. Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, Trackman PC, Spicer DB, Rosenberg L, Palmer JR, Sonenshein GE. 2009. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res 69: 6685- 6693.
76. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. 1996. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 87: 439- 446.
77. Mortensen M, Watson AS, Simon AK. 2011. Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy 7: 1069- 1070.
78. Mostafa SS, Miller WM, Papoutsakis ET. 2000. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 111: 879- 889.
79. Mostafa SS, Papoutsakis ET, Miller WM. 2001. Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes. Exp Hematol 29: 873- 883.
80. Motohashi H, Kimura M, Fujita R, Inoue A, Pan X, Takayama M, Katsuoka F, Aburatani H, Bresnick EH, Yamamoto M. 2010. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood 115: 677- 686.
81. Nelson JM, Diegelmann RF, Cohen IK. 1988. Effect of beta-aminopropionitrile and ascorbate on fibroblast migration. Proc Soc Exp Biol Med 188: 346- 352.
82. O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, Palis J, Seweryniak KE, Gertz JM, Phipps RP. 2008. 15-Deoxy-delta12, 14-PGJ2 enhances platelet production from megakaryocytes. Blood 112: 4051- 4060.
83. Pallotta I, Lovett M, Rice W, Kaplan DL, Balduini A. 2009. Bone marrow osteoblastic niche: A new model to study physiological regulation of megakaryopoiesis. PLoS ONE 4: e8359.
84. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD. 2007. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104: 5431- 5436.
85. Paulus JM. 1970. DNA metabolism and development of organelles in guinea-pig megakaryocytes: A combined ultrastructural, autoradiographic and cytophotometric study. Blood 35: 298- 311.
86. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SFT, Csiszar K, Hendrix MJC, Kirschmann DA. 2005. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65: 11429- 11436.
87. Pennathur-Das R, Levitt L. 1987. Augmentation of in vitro human marrow erythropoiesis under physiological oxygen tensions is mediated by monocytes and T lymphocytes. Blood 69: 899- 907.
88. Piccoli C, Ria R, Scrima R, Cela O, D'Aprile A, Boffoli D, Falzetti F, Tabilio A, Capitanio N. 2005. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem 280: 26467- 26476.
89. Piccoli C, D'Aprile A, Ripoli M, Scrima R, Boffoli D, Tabilio A, Capitanio N. 2007a. The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions. FEBS Lett 581: 3111- 3119.
90. Piccoli C, D'Aprile A, Ripoli M, Scrima R, Lecce L, Boffoli D, Tabilio A, Capitanio N. 2007b. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochem Biophys Res Commun 353: 965- 972.
91. Prata C, Maraldi T, Zambonin L, Fiorentini D, Hakim G, Landi L. 2004. ROS production and Glut1 activity in two human megakaryocytic cell lines. Biofactors 20: 223- 233.
92. Ranjan P, Anathy V, Burch PM, Weirather K, Lambeth JD, Heintz NH. 2006. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid Redox Signal 8: 1447- 1459.
93. Rao GN. 1997. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal 9: 181- 187.
94. Raslova H, Baccini V, Loussaief L, Comba B, Larghero J, Debili N, Vainchenker W. 2006. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood 107: 2303- 2310.
95. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A. 1993. Characterization of an acute micromegakaryocytic leukaemia: Evidence for the pathogenesis of myelofibrosis. Br J Haematol 83: 58- 62.
96. Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia JF, Guadall A, Badimon L. 2008. Regulation of lysyl oxidase in vascular cells: Lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res 79: 7- 13.
97. Rossi F, Zatti M. 1964. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20: 21- 23.
98. Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D. 1997. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57: 2839- 2842.
99. Salvemini D, de Nucci G, Vane JR. 1991. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: A comparative study in washed platelets and platelet rich plasma. Thromb Haemost 65: 421- 424.
100. Sardina JL, Lopez-Ruano G, Sanchez-Abarca LI, Perez-Simon JA, Gaztelumendi A, Trigueros C, Llanillo M, Sanchez-Yague J, Hernandez-Hernandez A. 2010. p22phox-Dependent NADPH oxidase activity is required for megakaryocytic differentiation. Cell Death Differ 17: 1842- 1854.
101. Sardina JL, Lopez-Ruano G, Sanchez-Sanchez B, Llanillo M, Hernandez-Hernandez A. 2011. Reactive oxygen species: Are they important for haematopoiesis? Crit Rev Oncol Hematol 81: 257- 274.
102. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, Griffin JD. 1999. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93: 2928- 2935.
103. Schattner M, Pozner RG, Gorostizaga AB, Lazzari MA. 2000. Effect of thrombopoietin and granulocyte colony-stimulating factor on platelets and polymorphonuclear leukocytes. Thromb Res 99: 147- 154.
104. Schmidt KN, Amstad P, Cerutti P, Baeuerle PA. 1996. Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-kappaB. Adv Exp Med Biol 387: 63- 68.
105. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247- 2258.
106. Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, Yamada S, Hirata KI, Kawashima S, Tawa R, Imajoh-Ohmi S, Sakurai H, Yokoyama M. 2001. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 103: 399- 409.
107. Severin S, Ghevaert C, Mazharian A. 2010. The mitogen-activated protein kinase signaling pathways: Role in megakaryocyte differentiation. J Thromb Haemost 8: 17- 26.
108. Shao L, Li H, Pazhanisamy SK, Meng A, Wang Y, Zhou D. 2011. Reactive oxygen species and hematopoietic stem cell senescence. Int J Hematol 94: 24- 32.
109. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81: 695- 704.
110. Slater DN, Trowbridge EA, Martin JF. 1983. The megakaryocyte in thrombocytopenia: A microscopic study which supports the theory that platelets are produced in the pulmonary circulation. Thromb Res 31: 163- 176.
111. Stocker R, Keaney JF, Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381- 1478.
112. Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PM. 2001. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant 27: 1075- 1080.
113. Su RJ, Li K, Zhang XB, Pan Yuen PM, Li CK, James AE, Liu J, Fok TF. 2005. Platelet-derived growth factor enhances expansion of umbilical cord blood CD34+ cells in contact with hematopoietic stroma. Stem Cells Dev 14: 223- 230.
114. Suda T, Takubo K, Semenza GL. 2011. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9: 298- 310.
115. Sungaran R, Markovic B, Chong BH. 1997. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89: 101- 107.
116. Sungaran R, Chisholm OT, Markovic B, Khachigian LM, Tanaka Y, Chong BH. 2000. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood 95: 3094- 3101.
117. Tang SS, Trackman PC, Kagan HM. 1983. Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J Biol Chem 258: 4331- 4338.
118. Tauro S, Hepburn MD, Bowen DT, Pippard MJ. 2001. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica 86: 1038- 1045.
119. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H. 1990. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75: 1540- 1548.
120. Tomer A. 2004. Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes. Blood 104: 2722- 2727.
121. Tonks NK. 2005. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 121: 667- 670.
122. Trackman PC, Bedell-Hogan D, Tang J, Kagan HM. 1992. Post-translational glycosylation and proteolytic processing of a lysyl oxidase precursor. J Biol Chem 267: 8666- 8671.
123. Turrens JF. 2003. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335- 344.
124. Vannucchi AM, Bianchi L, Cellai C, Paoletti F, Rana RA, Lorenzini R, Migliaccio G, Migliaccio AR. 2002. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood 100: 1123- 1132.
125. Vener C, Novembrino C, Catena FB, Fracchiolla NS, Gianelli U, Savi F, Radaelli F, Fermo E, Cortelezzi A, Lonati S, Menegatti M, Deliliers GL. 2010. Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis. Exp Hematol 38: 1058- 1065.
126. Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. 1995. Cyclin D3 is essential for megakaryocytopoiesis. Blood 86: 3783- 3788.
127. Wang X, McCullough KD, Franke TF, Holbrook NJ. 2000. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 275: 14624- 14631.
128. Watson AS, Mortensen M, Simon AK. 2011. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia. Cell Cycle 10: 1719- 1725.
129. Yang M, Chesterman CN, Chong BH. 1995. Recombinant PDGF enhances megakaryocytopoiesis in vitro. Br J Haematol 91: 285- 289.
130. Zhang P, Wang YZ, Kagan E, Bonner JC. 2000. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275: 22479- 22486.
131. Zimmet JM, Ladd D, Jackson CW, Stenberg PE, Ravid K. 1997. A role for cyclin D3 in the endomitotic cell cycle. Mol Cell Biol 17: 7248- 7259.
132. Zucker-Franklin D, Philipp CS. 2000. Platelet production in the pulmonary capillary bed: New ultrastructural evidence for an old concept. Am J Pathol 157: 69- 74.